Antipsychotic medication use by older adults

JAMA Psychiatry

2025-12-03

(Press-News.org) About The Study: This cross-sectional study found that older U.S. adults are increasingly treated with antipsychotics, with a growing share receiving them from long-term care pharmacies and a declining percentage from psychiatrists and for first-generation medications. An increase in prescribing by non-psychiatrists contributed to the overall trend.

Corresponding Author: To contact the corresponding author, Mark Olfson, MD, MPH, email mo49@cumc.columbia.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(10.1001/jamapsychiatry.2025.3658)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2025.3658?guestAccessKey=03599630-c7b7-4547-8bb7-304dbc49c862&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120325

END

ELSE PRESS RELEASES FROM THIS DATE:

Statewide analysis quantifies life-saving potential of stop the bleed

2025-12-03

Key Takeaways In an analysis of more than 5,000 Maryland homicide victims who died from gunshot or stabbing wounds, more than 70 individuals could have survived if bleeding control techniques had been applied before arriving at the hospital — a small but significant and likely under-reported number, trauma experts said. Research underscores the life-saving potential of Stop the Bleed for both urban and rural communities, where access to trauma care may be delayed. CHICAGO — Quicker access to bleeding control interventions taught in the American College of ...

Complex life developed earlier than previously thought, new study reveals

2025-12-03

Complex life began to develop earlier, and over a longer span of time, than previously believed, a groundbreaking new study has revealed. The research sheds new light on the conditions needed for early organisms to evolve and challenges several long-standing scientific theories in this area. Led by the University of Bristol and published in the journal Nature today [3 December], the research indicates that complex organisms evolved long before there were substantial levels of oxygen in the atmosphere, ...

Semaglutide and early-stage metabolic abnormalities in individuals with schizophrenia spectrum disorders

2025-12-03

About The Study: The results of this randomized clinical trial show that adjunctive semaglutide significantly improved glycemic control and weight outcomes in individuals with schizophrenia spectrum disorders. Secondary outcomes were exploratory. These findings support the use of glucagon-like peptide–1 receptor agonists (GLP-1RAs) as a potential early intervention strategy to reduce cardiometabolic risk in this vulnerable population. Corresponding Author: To contact the corresponding author, Anders Fink-Jensen, DMSci, email anders.fink-jensen@regionh.dk. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (10.1001/jamapsychiatry.2025.3639) Editor’s ...

Robert Wood Johnson University Hospital and Rutgers Robert Wood Johnson Medical School receive National Rare Disease Center of Excellence recognition

2025-12-03

Robert Wood Johnson University Hospital (RWJUH), an RWJBarnabas Health facility, in partnership with Rutgers Robert Wood Johnson Medical School (RWJMS), has been designated a National Rare Disease Center of Excellence by the National Organization for Rare Disorders (NORD). RWJUH is the first hospital in the state to receive this designation making New Jersey one of just 26 states in the U.S. to host such a Center of Excellence. RWJUH and RWJMS were selected for this designation based on the strength and impact of their Cardiac Amyloidosis Center, which was recently named an International Center of Excellence by the International Society of Amyloidosis (ISA). ...

The Mohn Prize for 2026 awarded to Canadian John Smol

2025-12-03

Professor John Smol of Queen's University is being honoured for his role in identifying stressors of environmental change in the Arctic. During the Arctic Futures Symposium in Brussels, UiT Rector Dag Rune Olsen announced today that the Mohn Prize for 2026 will be awarded to Professor John P. Smol of Queen’s University in Ontario, Canada. “Professor Smol's scientific career is a testament to excellent Arctic research - collaborative, engaged, thorough and key to the preservation of the environment we depend on. I am truly impressed by his comprehensive body of work and his longevity. He is a role model for us all.” said Olsen, who also ...

Americans more likely to accept guidance from AMA than CDC on vaccine safety

2025-12-03

PHILADELPHIA – For decades, health-related statements by major professional health associations such as the American Medical Association (AMA) agreed with those of the Centers for Disease Control and Prevention (CDC) because both relied on the same body of scientific knowledge, much of it funded by the federal health sector. However, the public can no longer assume that the CDC and major public health organizations are on the same page. In late November 2025, for example, when the CDC website legitimized the ...

How two Russian scientists changed the way we understand aging and cancer

2025-12-03

“Here, conceptual similarities between Mikhail Blagosklonny’s hyperfunction theory of aging and Vladimir Dilman’s elevation theory of aging are considered.” BUFFALO, NY — December 3, 2025 — A new essay was published in Volume 17, Issue 11 of Aging-US on November 19, 2025, titled “On the intergenerational transfer of ideas in aging and cancer research: from the hypothalamus according to V.M. Dilman to the mTOR protein complex according to M.V. Blagosklonny.” In this work, ...

Noninvasive imaging could replace finger pricks for people with diabetes

2025-12-03

CAMBRIDGE, MA -- A noninvasive method for measuring blood glucose levels, developed at MIT, could save diabetes patients from having to prick their fingers several times a day. The MIT team used Raman spectroscopy — a technique that reveals the chemical composition of tissues by shining near-infrared or visible light on them — to develop a shoebox-sized device that can measure blood glucose levels without any needles. In tests in a healthy volunteer, the researchers found that the measurements from their device were similar to those obtained by commercial ...

Genome Research publishes a special issue on advances in computational biology and their applications in genomics

2025-12-03

December 1, 2025 – This month Genome Research (https://genome.org) publishes a special issue highlighting novel advances in computational biology. In collaboration with the 29th International Conference on Research in Computational Molecular Biology (RECOMB), Genome Research publishes a collection of novel computational methods and their applications in genomics, including single-cell and spatial transcriptomics. These include algorithmic innovations in haplotype assembly and phasing, the analysis of genomic variation and its association to phenotype, and metagenomic ...

Announcing the 2025 Glenn Foundation for Medical Research Discovery Awards: Christina Camell, PhD (University of Minnesota) and Elaine Fuchs, PhD (The Rockefeller University)

2025-12-03

Santa Barbara, CA and New York, NY -- The Glenn Foundation for Medical Research (GFMR) and the American Federation for Aging Research (AFAR) are pleased to announce the 2025 recipients of the Glenn Foundation for Medical Research Discovery Awards: Christina Camell, PhD (Associate Professor, University of Minnesota) and Elaine Fuchs, PhD (Rebecca C. Lancefield Professor, The Rockefeller University and Investigator, Howard Hughes Medical Institute). The Glenn Foundation for Medical Discovery Awards support ...

LAST 30 PRESS RELEASES:

Scientists design solar-responsive biochar that accelerates environmental cleanup

Construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases

Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy

DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer

Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model

Neg-entropy is the true drug target for chronic diseases

Oxygen-boosted dual-section microneedle patch for enhanced drug penetration and improved photodynamic and anti-inflammatory therapy in psoriasis

Around the world, children’s cooperative behaviors and norms converge toward community-specific norms in middle childhood, Boston College researchers report